Interestingly, the silencing of p21 expression in human non-small cell lung carcinoma (NSCLCs) cells abolished the antiproliferative effect of GHRH antagonist JMR-132 [47]. The gene discussed is GHRH; the disease is non-small cell lung carcinoma.